For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Ancestral antibiotic resistance in Mycobacterium tuberculosis.

TitleAncestral antibiotic resistance in Mycobacterium tuberculosis.
Publication TypeJournal Article
Year of Publication2005
AuthorsMorris RP, Nguyen L, Gatfield J, Visconti K, Nguyen K, Schnappinger D, Ehrt S, Liu Y, Heifets L, Pieters J, Schoolnik G, Thompson CJ
JournalProc Natl Acad Sci U S A
Volume102
Issue34
Pagination12200-5
Date Published2005 Aug 23
ISSN0027-8424
KeywordsAnti-Bacterial Agents, Bacterial Proteins, Base Sequence, DNA Mutational Analysis, Drug Resistance, Multiple, Bacterial, Evolution, Molecular, Fatty Acids, Gene Expression Profiling, Gene Expression Regulation, Bacterial, Molecular Sequence Data, Mycobacterium tuberculosis, Plasmids, Regulon, Reverse Transcriptase Polymerase Chain Reaction, Sequence Analysis, DNA, Streptomyces coelicolor, Transcription Factors
Abstract

Chemotherapeutic options to treat tuberculosis are severely restricted by the intrinsic resistance of Mycobacterium tuberculosis to the majority of clinically applied antibiotics. Such resistance is partially provided by the low permeability of their unique cell envelope. Here we describe a complementary system that coordinates resistance to drugs that have penetrated the envelope, allowing mycobacteria to tolerate diverse classes of antibiotics that inhibit cytoplasmic targets. This system depends on whiB7, a gene that pathogenic Mycobacterium shares with Streptomyces, a phylogenetically related genus known as the source of diverse antibiotics. In M. tuberculosis, whiB7 is induced by subinhibitory concentrations of antibiotics (erythromycin, tetracycline, and streptomycin) and whiB7 null mutants (Streptomyces and Mycobacterium) are hypersusceptible to antibiotics in vitro. M. tuberculosis is also antibiotic sensitive within a monocyte model system. In addition to antibiotics, whiB7 is induced by exposure to fatty acids that pathogenic Mycobacterium species may accumulate internally or encounter within eukaryotic hosts during infection. Gene expression profiling analyses demonstrate that whiB7 transcription determines drug resistance by activating expression of a regulon including genes involved in ribosomal protection and antibiotic efflux. Components of the whiB7 system may serve as attractive targets for the identification of inhibitors that render M. tuberculosis or multidrug-resistant derivatives more antibiotic-sensitive.

DOI10.1073/pnas.0505446102
Alternate JournalProc Natl Acad Sci U S A
PubMed ID16103351
PubMed Central IDPMC1186028
Grant ListR01 AI044826 / AI / NIAID NIH HHS / United States
AI 44826 / AI / NIAID NIH HHS / United States

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587